Browsing publications by Professor Steve Wedge

Newcastle AuthorsTitleYearFull text
Dominic Jones
Dr Mark Wade
Jim Grey
Sirintra Nakjang
Wenrui Guo
et al.
Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy2015
Elisa Meschini
Dr Mathew Martin
Dr Will Stanley
Tristan Reuillon
Professor Bernard Golding
et al.
Identification and characterization of an irreversible inhibitor of CDK22015
Dr Mathew Martin
Elisa Meschini
Lan Wang
Dr Regina Mora Vidal
Tristan Reuillon
et al.
Identification and characterization of an irreversible inhibitor of CDK22014
Professor Steve Wedge
Mechanisms that influence tumour response to VEGF-pathway inhibitors2014
Annalisa Bertoli
Santosh Adhikari
Dr Suzannah Harnor
Dr Yan Zhao
Professor John Lunec
et al.
Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction2014
Sarah Jane Ross
Dr Fadhel Shaheen
Dr Luke Gaughan
Professor Craig Robson
Professor Steve Wedge
et al.
AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function In Vitro and In Vivo2013
Professor Steve Wedge
Tumour-stromal architecture can define the intrinsic tumour response to VEGF-targeted therapy2013
Professor Steve Wedge
An evaluation of 2-deoxy-2- [18F]fluoro-D-glucose and 3‟-Deoxy-3‟-[18F]-fluorothymidine uptake in human tumor xenograft models2012
Professor Steve Wedge
Expression of stromal genes associated with the angiogenic response are not differentiated between human tumour xenografts with divergent vascular morphologies2012
Professor Steve Wedge
Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia2012
123456